Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation

Journal of Immunology

Volumn 187, Issue 1, 2011, Pages 424-433

  Avirutnan, Panisadee ^a,b   Hauhart, Richard E ^a   Somnuke, Pawit ^a,c   Blom, Anna M ^d   Diamond, Michael S ^a   Atkinson, John P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4B BINDING PROTEIN; LECTIN; NONSTRUCTURAL PROTEIN 1;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL MEMBRANE; CELL STRAIN BHK; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; COMPLEX FORMATION; CONTROLLED STUDY; DENGUE VIRUS; FLAVIVIRUS; FLAVIVIRUS INFECTION; IMMUNE EVASION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN TRANSPORT; VIRUS PARTICLE; WEST NILE FLAVIVIRUS; YELLOW FEVER FLAVIVIRUS;

ANIMALS; CELL LINE; COMPLEMENT ACTIVATION; COMPLEMENT C4B; CRICETINAE; DENGUE VIRUS; FLAVIVIRUS; HISTOCOMPATIBILITY ANTIGENS; HUMANS; PROTEIN BINDING; VIRAL NONSTRUCTURAL PROTEINS; WEST NILE VIRUS; YELLOW FEVER VIRUS;

EID: 79960404180     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100750     Document Type: Article

References (74)

1. Avirutnan, P., E. Mehlhop, and M. S. Diamond. 2008. Complement and its role in protection and pathogenesis of flavivirus infections. Vaccine 26(Suppl 8): I100-I107.
2. Stoermer, K. A., and T. E. Morrison. 2011. Complement and viral pathogenesis. Virology 411: 362-373.
3. Lambris, J. D., D. Ricklin, and B. V. Geisbrecht. 2008. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6: 132-142.
4. Dahlbäck, B., C. A. Smith, and H. J. Müller-Eberhard. 1983. Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b. Proc. Natl. Acad. Sci. USA 80: 3461-3465.
5. de Cordoba, S. R., O. C. Garcia, and P. Sanchez-Corral. 2000. C4b-binding protein. In The complement facts book. B. J. Morley, and M. J. Walport, eds. Academic Press, London, p. 161-167.
6. Rodriguez de Cordoba, S., P. Sanchez-Corral, and J. Rey-Campos. 1991. Structure of the gene coding for the alpha polypeptide chain of the human complement component C4b-binding protein. J. Exp. Med. 173: 1073-1082.
7. Blom, A. M., L. Kask, and B. Dahlbäck. 2001. Structural requirements for the complement regulatory activities of C4BP. J. Biol. Chem. 276: 27136-27144.
8. Blom, A. M., J. Webb, B. O. Villoutreix, and B. Dahlbäck. 1999. A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function. J. Biol. Chem. 274: 19237-19245.
9. Fujita, T., and V. Nussenzweig. 1979. The role of C4-binding protein and beta 1H in proteolysis of C4b and C3b. J. Exp. Med. 150: 267-276.
10. Fujita, T., and N. Tamura. 1983. Interaction of C4-binding protein with cellbound C4b. A quantitative analysis of binding and the role of C4-binding protein in proteolysis of cell-bound C4b. J. Exp. Med. 157: 1239-1251.
11. Brodeur, S. R., F. Angelini, L. B. Bacharier, A. M. Blom, E. Mizoguchi, H. Fujiwara, A. Plebani, L. D. Notarangelo, B. Dahlback, E. Tsitsikov, and R. S. Geha. 2003. C4b-binding protein (C4BP) activates B cells through the CD40 receptor. Immunity 18: 837-848.
12. Williams, K. T., S. P. Young, A. Negus, L. S. Young, D. H. Adams, and S. C. Afford. 2007. C4b binding protein binds to CD154 preventing CD40 mediated cholangiocyte apoptosis: a novel link between complement and epithelial cell survival. PLoS ONE 2: e159.
13. Spijkers, P. P., C. V. Denis, A. M. Blom, and P. J. Lenting. 2008. Cellular uptake of C4b-binding protein is mediated by heparan sulfate proteoglycans and CD91/LDL receptor-related protein. Eur. J. Immunol. 38: 809-817.
14. Shayakhmetov, D. M., A. Gaggar, S. Ni, Z. Y. Li, and A. Lieber. 2005. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J. Virol. 79: 7478-7491. (Pubitemid 40756784)
15. Holmberg, M. T., A. M. Blom, and S. Meri. 2001. Regulation of complement classical pathway by association of C4b-binding protein to the surfaces of SK-OV-3 and Caov-3 ovarian adenocarcinoma cells. J. Immunol. 167: 935-939. (Pubitemid 32660850)
16. Trouw, L. A., A. A. Bengtsson, K. A. Gelderman, B. Dahlbäck, G. Sturfelt, and A. M. Blom. 2007. C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack. J. Biol. Chem. 282: 28540-28548.
17. Trouw, L. A., S. C. Nilsson, I. Gonçalves, G. Landberg, and A. M. Blom. 2005. C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. J. Exp. Med. 201: 1937-1948.
18. Lindenbach, B. D., H.-J. Thiel, and C. Rice. 2007. Flaviviridae: the viruses and their replication. In Field's Virology, 5th ed. D. M. Knipe, and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia. p. 1101-1152.
19. Khromykh, A. A., P. L. Sedlak, K. J. Guyatt, R. A. Hall, and E. G. Westaway. 1999. Efficient trans-complementation of the flavivirus kunjin NS5 protein but not of the NS1 protein requires its coexpression with other components of the viral replicase. J. Virol. 73: 10272-10280.
20. Lindenbach, B. D., and C. M. Rice. 1997. trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J. Virol. 71: 9608-9617.
21. Mackenzie, J. M., M. K. Jones, and P. R. Young. 1996. Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220: 232-240.
22. Flamand, M., F. Megret, M. Mathieu, J. Lepault, F. A. Rey, and V. Deubel. 1999. Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J. Virol. 73: 6104-6110. (Pubitemid 29274901)
23. Crooks, A. J., J. M. Lee, L. M. Easterbrook, A. V. Timofeev, and J. R. Stephenson. 1994. The NS1 protein of tick-borne encephalitis virus forms multimeric species upon secretion from the host cell. J. Gen. Virol. 75: 3453-3460.
24. Winkler, G., S. E. Maxwell, C. Ruemmler, and V. Stollar. 1989. Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology 171: 302-305. (Pubitemid 19180804)
25. Winkler, G., V. B. Randolph, G. R. Cleaves, T. E. Ryan, and V. Stollar. 1988. Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer. Virology 162: 187-196. (Pubitemid 18063113)
26. Avirutnan, P., L. Zhang, N. Punyadee, A. Manuyakorn, C. Puttikhunt, W. Kasinrerk, P. Malasit, J. P. Atkinson, and M. S. Diamond. 2007. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog. 3: e183.
27. Libraty, D. H., P. R. Young, D. Pickering, T. P. Endy, S. Kalayanarooj, S. Green, D. W. Vaughn, A. Nisalak, F. A. Ennis, and A. L. Rothman. 2002. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J. Infect. Dis. 186: 1165-1168.
28. Avirutnan, P., N. Punyadee, S. Noisakran, C. Komoltri, S. Thiemmeca, K. Auethavornanan, A. Jairungsri, R. Kanlaya, N. Tangthawornchaikul, C. Puttikhunt, et al. 2006. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J. Infect. Dis. 193: 1078-1088.
29. Chang, H. H., H. F. Shyu, Y. M. Wang, D. S. Sun, R. H. Shyu, S. S. Tang, and Y. S. Huang. 2002. Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen. J. Infect. Dis. 186: 743-751.
30. Falconar, A. K. 1997. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch. Virol. 142: 897-916.
31. Sun, D. S., C. C. King, H. S. Huang, Y. L. Shih, C. C. Lee, W. J. Tsai, C. C. Yu, and H. H. Chang. 2007. Antiplatelet autoantibodies elicited by dengue virus nonstructural protein 1 cause thrombocytopenia and mortality in mice. J. Thromb. Haemost. 5: 2291-2299.
32. Lin, C. F., H. Y. Lei, A. L. Shiau, C. C. Liu, H. S. Liu, T. M. Yeh, S. H. Chen, and Y. S. Lin. 2003. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J. Med. Virol. 69: 82-90.
33. Alcon-LePoder, S., M. T. Drouet, P. Roux, M. P. Frenkiel, M. Arborio, A. M. Durand-Schneider, M. Maurice, I. Le Blanc, J. Gruenberg, and M. Flamand. 2005. The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity. J. Virol. 79: 11403-11411. (Pubitemid 41170681)
34. Chung, K. M., G. E. Nybakken, B. S. Thompson, M. J. Engle, A. Marri, D. H. Fremont, and M. S. Diamond. 2006. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J. Virol. 80: 1340-1351.
35. Chung, K. M., B. S. Thompson, D. H. Fremont, and M. S. Diamond. 2007. Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells. J. Virol. 81: 9551-9555.
36. Desprès, P., J. Dietrich, M. Girard, and M. Bouloy. 1991. Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice. J. Gen. Virol. 72: 2811-2816.
37. Falgout, B., M. Bray, J. J. Schlesinger, and C. J. Lai. 1990. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J. Virol. 64: 4356-4363.
38. Gould, E. A., A. Buckley, A. D. Barrett, and N. Cammack. 1986. Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J. Gen. Virol. 67: 591-595.
39. Henchal, E. A., L. S. Henchal, and J. J. Schlesinger. 1988. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J. Gen. Virol. 69: 2101-2107.
40. Jacobs, S. C., J. R. Stephenson, and G. W. Wilkinson. 1992. High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirusbased vector: protection elicited in a murine model. J. Virol. 66: 2086-2095.
41. Jacobs, S. C., J. R. Stephenson, and G. W. Wilkinson. 1994. Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1. J. Gen. Virol. 75: 2399-2402.
42. Schlesinger, J. J., M. W. Brandriss, C. B. Cropp, and T. P. Monath. 1986. Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J. Virol. 60: 1153-1155.
43. Schlesinger, J. J., M. W. Brandriss, and E. E. Walsh. 1985. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J. Immunol. 135: 2805-2809.
44. Schlesinger, J. J., M. W. Brandriss, and E. E. Walsh. 1987. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J. Gen. Virol. 68: 853-857.
45. Schlesinger, J. J., M. Foltzer, and S. Chapman. 1993. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 192: 132-141.
46. Krishna, V. D., M. Rangappa, and V. Satchidanandam. 2009. Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells. J. Virol. 83: 4766-4777.
47. Chung, K. M., M. K. Liszewski, G. Nybakken, A. E. Davis, R. R. Townsend, D. H. Fremont, J. P. Atkinson, and M. S. Diamond. 2006. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc. Natl. Acad. Sci. USA 103: 19111-19116.
48. Avirutnan, P., A. Fuchs, R. E. Hauhart, P. Somnuke, S. Youn, M. S. Diamond, and J. P. Atkinson. 2010. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J. Exp. Med. 207: 793-806.
49. Kask, L., L. A. Trouw, B. Dahlbäck, and A. M. Blom. 2004. The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells. J. Biol. Chem. 279: 23869-23873.
50. Puttikhunt, C., W. Kasinrerk, S. Srisa-ad, T. Duangchinda, W. Silakate, S. Moonsom, N. Sittisombut, and P. Malasit. 2003. Production of anti-dengue NS1 monoclonal antibodies by DNA immunization. J. Virol. Methods 109: 55-61. (Pubitemid 36355886)
51. Härdig, Y., A. Hillarp, and B. Dahlbäck. 1997. The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor Icofactor function. Biochem. J. 323: 469-475. (Pubitemid 27183132)
52. Blom, A. M., B. O. Villoutreix, and B. Dahlbäck. 2004. Complement inhibitor C4b-binding protein-friend or foe in the innate immune system? Mol. Immunol. 40: 1333-1346. (Pubitemid 38456985)
53. Blom, A. M., and S. Ram. 2008. Contribution of interactions between complement inhibitor C4b-binding protein and pathogens to their ability to establish infection with particular emphasis on Neisseria gonorrhoeae. Vaccine 26(Suppl 8): I49-I55.
54. Haapasalo, K., T. Meri, and T. S. Jokiranta. 2009. Loa loa Microfilariae evade complement attack in vivo by acquiring regulatory proteins from host plasma. Infect. Immun. 77: 3886-3893.
55. Carlsson, F., K. Berggård, M. Stålhammar-Carlemalm, and G. Lindahl. 2003. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein. J. Exp. Med. 198: 1057-1068.
56. Accardo, P., P. Sánchez-Corral, O. Criado, E. García, and S. Rodríguez de Córdoba. 1996. Binding of human complement component C4b-binding protein (C4BP) to Streptococcus pyogenes involves the C4b-binding site. J. Immunol. 157: 4935-4939. (Pubitemid 126449570)
57. Barbosa, A. S., D. Monaris, L. B. Silva, Z. M. Morais, S. A. Vasconcellos, A. M. Cianciarullo, L. Isaac, and P. A. Abreu. 2010. Functional characterization of LcpA, a surface-exposed protein of Leptospira spp. that binds the human complement regulator C4BP. Infect. Immun. 78: 3207-3216.
58. Blom, A. M., K. Berggârd, J. H. Webb, G. Lindahl, B. O. Villoutreix, and B. Dahlbäck. 2000. Human C4b-binding protein has overlapping, but not identical, binding sites for C4b and streptococcal M proteins. J. Immunol. 164: 5328-5336. (Pubitemid 30305212)
59. Blom, A. M., A. Rytkönen, P. Vasquez, G. Lindahl, B. Dahlbäck, and A. B. Jonsson. 2001. A novel interaction between type IV pili of Neisseria gonorrhoeae and the human complement regulator C4B-binding protein. J. Immunol. 166: 6764-6770.
60. Grosskinsky, S., M. Schott, C. Brenner, S. J. Cutler, M. M. Simon, and R. Wallich. 2010. Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis. PLoS Negl. Trop. Dis. 4: e698.
61. Johnsson, E., A. Thern, B. Dahlbäck, L. O. Hedén, M. Wikström, and G. Lindahl. 1996. A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP. J. Immunol. 157: 3021-3029. (Pubitemid 126450061)
62. Kamdar, H. V., K. B. Rowley, D. Clements, and S. S. Patil. 1991. Pseudomonas syringae pv. phaseolicola genomic clones harboring heterologous DNA sequences suppress the same phaseolotoxin-deficient mutants. J. Bacteriol. 173: 1073-1079.
63. Morfeldt, E., K. Berggård, J. Persson, T. Drakenberg, E. Johnsson, E. Lindahl, S. Linse, and G. Lindahl. 2001. Isolated hypervariable regions derived from streptococcal M proteins specifically bind human C4b-binding protein: implications for antigenic variation. J. Immunol. 167: 3870-3877. (Pubitemid 32910831)
64. Nordström, T., A. M. Blom, A. Forsgren, and K. Riesbeck. 2004. The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2. J. Immunol. 173: 4598-4606. (Pubitemid 39280693)
65. Pietikäinen, J., T. Meri, A. M. Blom, and S. Meri. 2010. Binding of the complement inhibitor C4b-binding protein to Lyme disease Borreliae. Mol. Immunol. 47: 1299-1305.
66. Ram, S., M. Cullinane, A. M. Blom, S. Gulati, D. P. McQuillen, B. G. Monks, C. O'Connell, R. Boden, C. Elkins, M. K. Pangburn, et al. 2001. Binding of C4bbinding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J. Exp. Med. 193: 281-295.
67. Weiser, J. N., and E. C. Gotschlich. 1991. Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect. Immun. 59: 2252-2258.
68. Prasadarao, N. V., A. M. Blom, B. O. Villoutreix, and L. C. Linsangan. 2002. A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1. J. Immunol. 169: 6352-6360.
69. Blitvich, B. J., J. S. Mackenzie, R. J. Coelen, M. J. Howard, and R. A. Hall. 1995. A novel complex formed between the flavivirus E and NS1 proteins: analysis of its structure and function. Arch. Virol. 140: 145-156.
70. Alcon, S., A. Talarmin, M. Debruyne, A. Falconar, V. Deubel, and M. Flamand. 2002. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J. Clin. Microbiol. 40: 376-381.
71. Fuchs, A., T. Y. Lin, D. W. Beasley, C. M. Stover, W. J. Schwaeble, T. C. Pierson, and M. S. Diamond. 2010. Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin. Cell Host Microbe 8: 186-195.
72. Mehlhop, E., and M. S. Diamond. 2006. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J. Exp. Med. 203: 1371-1381.
73. Fuchs, A., A. K. Pinto, W. J. Schwaeble, and M. S. Diamond. 2011. The lectin pathway of complement activation contributes to protection from West Nile virus infection. Virology 412: 101-109.
74. Morgan, B. P. 1990. Complement: Clinical Aspects and Relevance to Disease. Academic Press, London.